Vaccines for human respiratory virus
US5149650A · kind A · utility
73Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 1988 |
| Grant date | Sep 22, 1992 |
| Priority date | — |
| Expiry date | Jul 13, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18534
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention discloses compositions of DNA and proteins that are useful for preparing vaccines against human respiratory syncytial virus [HRSV]. The DNA compositions include structural genes coding for native structural viral proteins and immunogenic fragments of these proteins. Host cells transformed with the above DNA compositions are also disclosed. Vaccines made from the native structural viral proteins or immunogenic fragments are also disclosed as well as methods for protecting humans by inoculation with these vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.